Atlas Trials

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Clinical trial NCT01420783 · COMPLETED

Trial details

NCT number
NCT01420783
Sponsor
Bristol-Myers Squibb
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hematopoietic Neoplasm
Start date
2011-10-01
Primary completion
2012-11-01
Enrollment
81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.